Coffee drinkers have long assumed that caffeine is the active ingredient in any focus-boosting drink. A randomized, placebo-controlled trial in Nutrients suggests the picture is more nuanced. In middle-aged and older adults, a single dose of caffeine sharpened attention, but only continuous daily matcha intake increased how much work people got done on a stress-inducing task.
The study, led by Baba and colleagues and published in 2021, is a useful reminder that a food's effects may not be reducible to its most famous compound. It also comes with limits that are worth stating plainly.
What the researchers set out to test
Matcha is a powdered green tea. Because the whole leaf is consumed, it delivers more amino acids than other teas, including L-theanine, alongside caffeine. The same group had previously reported that continuous matcha intake improved attention and executive function in older adults. That raised an obvious question: is matcha just a delivery vehicle for caffeine, or does something else contribute?
To find out, the team compared matcha, caffeine and placebo. They also compared single-dose and continuous intake, and they added a stress element. The study was registered with the University Hospital Medical Information Network in Japan (UMIN000036578), and participants were Japanese adults in middle and older age.
How stress and cognition were measured
Two tools did most of the work:
- The Uchida-Kraepelin test (UKT). This is a long-running Japanese task built on continuous simple arithmetic, used here to induce mild acute psychological stress. The key output is the amount of work, meaning how much a person completes under sustained, monotonous pressure.
- Cognitrax. This is a computerized cognitive battery that captures domains such as attention and reaction time.
The design let the researchers separate two questions. How does a one-off dose affect performance? And does a habit of daily intake change how people cope when stress is applied?
The headline findings
As reported in the abstract:
- A single dose of caffeine improved attentional function during or after stress loading.
- A single dose of matcha shortened reaction time on Cognitrax, which the authors judged was likely due to its caffeine content.
- The matcha group increased its amount of work after continuous intake.
- The caffeine group increased its amount of work on the UKT only after a single dose, not with continued use.
The authors concluded that taking matcha with its caffeine improves both attention and work performance under psychological stress, compared with caffeine alone.
The abstract does not report effect sizes, sample sizes or doses, so none are quoted here. Anyone who wants magnitudes should read the full paper (DOI: 10.3390/nu13051700) rather than rely on summaries, including this one.
Why caffeine alone may not be the whole story
The authors credit the combination of caffeine with matcha's amino acids, particularly L-theanine. This is plausible, but the study does not prove it. The trial compared matcha with caffeine, not with caffeine plus isolated theanine, so it cannot say which matcha component drives the sustained effect.
The pattern in the data is still interesting. Caffeine's benefit looked acute: it helped attention in the moment and boosted work output after a single dose, but that output gain did not show up with continued use. This is consistent with the familiar idea that tolerance blunts caffeine's effects over time. Matcha's work-output gain appeared with continuous intake. That would fit a mechanism in which theanine and related compounds smooth or extend caffeine's effects, though the abstract stops short of demonstrating this.
Caveats worth keeping in mind
- Population. Participants were middle-aged and older Japanese adults. The results may not carry over to young people, to other populations, or to people with very different habitual caffeine intake.
- Mild, lab-induced stress. The UKT is a standardized arithmetic task. It resembles a monotonous deadline more than a family crisis or a high-stakes presentation.
- Mixed signals. Single-dose matcha showed faster reaction time that the authors attributed to caffeine, so matcha did not beat caffeine on every measure. Its edge was in sustained work output.
- One study. A single randomized trial from a research group that had already reported positive matcha findings should be treated as promising, not settled.
Practical takeaways
Matcha versus coffee for focus. If you need a quick lift in attention, caffeine from either source appears to do the job. If you work through long, grinding, stressful stretches, matcha's caffeine-plus-amino-acid package may offer something coffee does not. That inference comes from this study, not a head-to-head matcha-versus-coffee test.
Daily habit versus one-off. The sustained work-output gain showed up with continuous matcha intake. A single cup before a big day is unlikely to replicate that, while a routine might be a better fit.
Theanine stacking. The finding may encourage people to pair caffeine with L-theanine supplements. That is reasonable to explore, but this trial tested whole matcha, which contains many compounds beyond theanine. Don't assume an isolated theanine capsule produces the same results.
Who it's for. Adults in midlife and beyond who want steady performance under pressure are the closest match to the participants. People sensitive to caffeine, those with sleep problems, and anyone on medication or with a health condition should consult a clinician first. Matcha still contains caffeine.
Bottom line
This trial suggests that matcha is more than a caffeine delivery system. Caffeine sharpened attention on its own, but only regular matcha intake was linked to getting more done under mild stress. The result is encouraging and mechanistically sensible. It still calls for replication, larger and more diverse samples, and trials that isolate theanine's contribution before anyone treats it as a firm recommendation.
